Gjevre John A, Hurst Thomas S, Taylor-Gjevre Regina M, Cockcroft Donald W
Division of Respirology, Royal University Hospital, University of Saskatchewan, Saskatoon.
Can Respir J. 2006 Nov-Dec;13(8):433-7. doi: 10.1155/2006/198940.
The diagnosis of asthma is based on clinical symptoms, physical examination and pulmonary function tests, and can be very challenging. Most patients with asthma have a significant postbronchodilator response on spirometry indicating airway hyperresponsiveness. However, having a significant bronchodilator response by itself is not diagnostic of asthma. The definition of a 'significant' response has also been controversial. Many respirologists use the American Thoracic Society (ATS) postbronchodilator response criteria of 12% (provided it is 200 mL or greater) improvement in forced expiratory volume in 1 s (or forced vital capacity) from the baseline spirometry.
In the present study, 644 patients who met the ATS criteria for a significant postbronchodilator spirometric response were retrospectively reviewed. The staff respirologist's diagnosis of asthma, based on all clinical and pulmonary function data, was used as the standard for the diagnosis of asthma.
Relying on spirometric criteria alone was inadequate in asthma diagnosis because only 54.7% of 310 patients who met the ATS bronchodilator response criteria were thought to have clinical asthma. Increasing the postbronchodilator percentage improvement from the ATS criteria only marginally improved diagnostic specificity and resulted in a decline in sensitivity.
The results of the present study further emphasize the need to use spirometric criteria as a guide but not as an unimpeachable gold standard with which to make a diagnosis of asthma. The diagnosis of asthma depends on expert physician correlation of patient history, physical examination and pulmonary function test results.
哮喘的诊断基于临床症状、体格检查和肺功能测试,可能极具挑战性。大多数哮喘患者在肺量计检查中显示出显著的支气管扩张剂后反应,表明气道高反应性。然而,仅具有显著的支气管扩张剂反应本身并不能诊断哮喘。“显著”反应的定义也一直存在争议。许多呼吸科医生使用美国胸科学会(ATS)的支气管扩张剂后反应标准,即一秒用力呼气量(或用力肺活量)较基础肺量计检查结果改善12%(前提是改善量为200毫升或更多)。
在本研究中,对644名符合ATS显著支气管扩张剂后肺量计反应标准的患者进行了回顾性分析。以呼吸科工作人员基于所有临床和肺功能数据做出的哮喘诊断作为哮喘诊断的标准。
仅依靠肺量计标准进行哮喘诊断是不够的,因为在310名符合ATS支气管扩张剂反应标准的患者中,只有54.7%被认为患有临床哮喘。将支气管扩张剂后改善百分比提高到超出ATS标准,仅略微提高了诊断特异性,同时导致敏感性下降。
本研究结果进一步强调,需要将肺量计标准作为指导,但不能将其作为诊断哮喘的无可置疑的金标准。哮喘的诊断取决于专业医生对患者病史、体格检查和肺功能测试结果的综合判断。